Histogen Reports First Quarter 2023 Results and Provides Business Update

Provided By Globe Newswire

Last update: May 11, 2023

Received FDA Clearance of IND Application for Emricasan for the Treatment of Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Emricasan Treatment has Therapeutic Effect Against Bacterial Skin Infection in Mice